186 related articles for article (PubMed ID: 16707695)
21. Pathogenicity islands PAPI-1 and PAPI-2 contribute individually and synergistically to the virulence of Pseudomonas aeruginosa strain PA14.
Harrison EM; Carter ME; Luck S; Ou HY; He X; Deng Z; O'Callaghan C; Kadioglu A; Rajakumar K
Infect Immun; 2010 Apr; 78(4):1437-46. PubMed ID: 20123716
[TBL] [Abstract][Full Text] [Related]
22. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
[TBL] [Abstract][Full Text] [Related]
23. Effector ExoU from the type III secretion system is an important modulator of gene expression in lung epithelial cells in response to Pseudomonas aeruginosa infection.
McMorran B; Town L; Costelloe E; Palmer J; Engel J; Hume D; Wainwright B
Infect Immun; 2003 Oct; 71(10):6035-44. PubMed ID: 14500525
[TBL] [Abstract][Full Text] [Related]
24. The Pseudomonas aeruginosa pathogenicity island PAPI-1 is transferred via a novel type IV pilus.
Carter MQ; Chen J; Lory S
J Bacteriol; 2010 Jul; 192(13):3249-58. PubMed ID: 20363934
[TBL] [Abstract][Full Text] [Related]
25. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.
Finnan S; Morrissey JP; O'Gara F; Boyd EF
J Clin Microbiol; 2004 Dec; 42(12):5783-92. PubMed ID: 15583313
[TBL] [Abstract][Full Text] [Related]
26. Functional analysis of pyochelin-/enantiopyochelin-related genes from a pathogenicity island of Pseudomonas aeruginosa strain PA14.
Maspoli A; Wenner N; Mislin GL; Reimmann C
Biometals; 2014 Jun; 27(3):559-73. PubMed ID: 24682869
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis of transfer-related regions of the vancomycin resistance Enterococcus conjugative plasmid pHTbeta: identification of oriT and a putative relaxase gene.
Tomita H; Ike Y
J Bacteriol; 2005 Nov; 187(22):7727-37. PubMed ID: 16267297
[TBL] [Abstract][Full Text] [Related]
28. Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU.
Lee VT; Pukatzki S; Sato H; Kikawada E; Kazimirova AA; Huang J; Li X; Arm JP; Frank DW; Lory S
Infect Immun; 2007 Mar; 75(3):1089-98. PubMed ID: 17178785
[TBL] [Abstract][Full Text] [Related]
29. Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU.
Rabin SD; Hauser AR
Infect Immun; 2005 Jan; 73(1):573-82. PubMed ID: 15618197
[TBL] [Abstract][Full Text] [Related]
30. Pseudomonas aeruginosa PAO1 bacterial artificial chromosomes: strategies for mapping, screening, and sequencing 100 kb loci of the 5.9 Mb genome.
Dewar K; Sabbagh L; Cardinal G; Veilleux F; Sanschagrin F; Birren B; Levesque RC
Microb Comp Genomics; 1998; 3(2):105-17. PubMed ID: 9697095
[TBL] [Abstract][Full Text] [Related]
31. Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU.
Saliba AM; de Assis MC; Nishi R; Raymond B; Marques Ede A; Lopes UG; Touqui L; Plotkowski MC
Microbes Infect; 2006 Feb; 8(2):450-9. PubMed ID: 16293434
[TBL] [Abstract][Full Text] [Related]
32. ISPa20 advances the individual evolution of Pseudomonas aeruginosa clone C subclone C13 strains isolated from cystic fibrosis patients by insertional mutagenesis and genomic rearrangements.
Kresse AU; Blöcker H; Römling U
Arch Microbiol; 2006 May; 185(4):245-54. PubMed ID: 16474952
[TBL] [Abstract][Full Text] [Related]
33. Why? - Successful Pseudomonas aeruginosa clones with a focus on clone C.
Lee C; Klockgether J; Fischer S; Trcek J; Tümmler B; Römling U
FEMS Microbiol Rev; 2020 Nov; 44(6):740-762. PubMed ID: 32990729
[TBL] [Abstract][Full Text] [Related]
34. Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial.
Lee DG; Urbach JM; Wu G; Liberati NT; Feinbaum RL; Miyata S; Diggins LT; He J; Saucier M; Déziel E; Friedman L; Li L; Grills G; Montgomery K; Kucherlapati R; Rahme LG; Ausubel FM
Genome Biol; 2006; 7(10):R90. PubMed ID: 17038190
[TBL] [Abstract][Full Text] [Related]
35. Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain.
Lewis DA; Jones A; Parkhill J; Speert DP; Govan JR; Lipuma JJ; Lory S; Webb AK; Mahenthiralingam E
Am J Respir Cell Mol Biol; 2005 Jul; 33(1):56-64. PubMed ID: 15834046
[TBL] [Abstract][Full Text] [Related]
36. Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis.
Zhu H; Conibear TC; Bandara R; Aliwarga Y; Stapleton F; Willcox MD
Curr Eye Res; 2006 Apr; 31(4):297-306. PubMed ID: 16603462
[TBL] [Abstract][Full Text] [Related]
37. Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa.
Raymond CK; Sims EH; Kas A; Spencer DH; Kutyavin TV; Ivey RG; Zhou Y; Kaul R; Clendenning JB; Olson MV
J Bacteriol; 2002 Jul; 184(13):3614-22. PubMed ID: 12057956
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.
Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M
Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427
[TBL] [Abstract][Full Text] [Related]
39. ExoU Induces Lung Endothelial Cell Damage and Activates Pro-Inflammatory Caspase-1 during
Hardy KS; Tuckey AN; Renema P; Patel M; Al-Mehdi AB; Spadafora D; Schlumpf CA; Barrington RA; Alexeyev MF; Stevens T; Pittet JF; Wagener BM; Simmons JD; Alvarez DF; Audia JP
Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202178
[TBL] [Abstract][Full Text] [Related]
40. Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU.
Finck-Barbançon V; Frank DW
J Bacteriol; 2001 Jul; 183(14):4330-44. PubMed ID: 11418575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
